de Morgan Stanley Fresenius Medical Care FMS Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 98.3 M | Comprar |
4,347,748
+1,862,938
| +75% | +USD 41.8 M | 0.01% | 1579 |
|
|
2026
Q1 | USD 56.1 M | Vender |
2,484,810
-455,029
| -15% | -USD 10.5 M | ﹤0.01% | 1985 |
|
|
2025
Q4 | USD 70 M | Comprar |
2,939,839
+942,497
| +47% | +USD 23.4 M | ﹤0.01% | 1759 |
|
|
2025
Q3 | USD 52.6 M | Vender |
1,997,342
-371,747
| -16% | -USD 9.6 M | ﹤0.01% | 1966 |
|
|
2025
Q2 | USD 67.7 M | Comprar |
2,369,089
+1,318,405
| +125% | +USD 35.4 M | ﹤0.01% | 1643 |
|
|
2025
Q1 | USD 26.2 M | Comprar |
1,050,684
+15,725
| +2% | +USD 374 k | ﹤0.01% | 2421 |
|
|
2024
Q4 | USD 23.4 M | Comprar |
1,034,959
+3,057
| +0.3% | +USD 66.4 k | ﹤0.01% | 2601 |
|
|
2024
Q3 | USD 22 M | Comprar |
1,031,902
+53,322
| +5% | +USD 1.05 M | ﹤0.01% | 2708 |
|
|
2024
Q2 | USD 18.7 M | Vender |
978,580
-17,126
| -2% | -USD 349 k | ﹤0.01% | 2741 |
|
|
2024
Q1 | USD 19.2 M | Comprar |
995,706
+44,207
| +5% | +USD 876 k | ﹤0.01% | 2746 |
|
|
2023
Q4 | USD 19.8 M | Vender |
951,499
-89,948
| -9% | -USD 1.73 M | ﹤0.01% | 2697 |
|
|
2023
Q3 | USD 22.4 M | Comprar |
1,041,447
+36,820
| +4% | +USD 894 k | ﹤0.01% | 2329 |
|
|
2023
Q2 | USD 24 M | Vender |
1,004,627
-43,724
| -4% | -USD 1 M | ﹤0.01% | 2284 |
|
|
2023
Q1 | USD 22.3 M | Comprar |
1,048,351
+90,720
| +9% | +USD 1.74 M | ﹤0.01% | 2308 |
|
|
2022
Q4 | USD 15.6 M | Vender |
957,631
-96,486
| -9% | -USD 1.43 M | ﹤0.01% | 2589 |
|
|
2022
Q3 | USD 14.8 M | Comprar |
1,054,117
+610,550
| +138% | +USD 11.5 M | ﹤0.01% | 2538 |
|
|
2022
Q2 | USD 11.1 M | Comprar |
443,567
+253,592
| +133% | +USD 7.58 M | ﹤0.01% | 2974 |
|
|
2022
Q1 | USD 6.4 M | Vender |
189,975
-143,224
| -43% | -USD 4.71 M | ﹤0.01% | 3417 |
|
|
2021
Q4 | USD 10.8 M | Vender |
333,199
-174,317
| -34% | -USD 5.74 M | ﹤0.01% | 2871 |
|
|
2021
Q3 | USD 17.7 M | Vender |
507,516
-142,945
| -22% | -USD 5.58 M | ﹤0.01% | 2216 |
|
|
2021
Q2 | USD 27 M | Vender |
650,461
-149,863
| -19% | -USD 5.99 M | ﹤0.01% | 1837 |
|
|
2021
Q1 | USD 29.5 M | Vender |
800,324
-661,466
| -45% | -USD 25 M | ﹤0.01% | 1570 |
|
|
2020
Q4 | USD 60.8 M | Vender |
1,461,790
-155,305
| -10% | -USD 6.47 M | 0.01% | 953 |
|
|
2020
Q3 | USD 68.7 M | Vender |
1,617,095
-50,316
| -3% | -USD 2.17 M | 0.01% | 755 |
|
|
2020
Q2 | USD 72.2 M | Comprar |
1,667,411
+253,773
| +18% | +USD 10 M | 0.02% | 674 |
|
|
2020
Q1 | USD 46.4 M | Vender |
1,413,638
-547,252
| -28% | -USD 20.3 M | 0.01% | 770 |
|
|
2019
Q4 | USD 72.2 M | Comprar |
1,960,890
+459,548
| +31% | +USD 16.3 M | 0.02% | 755 |
|
|
2019
Q3 | USD 50.4 M | Vender |
1,501,342
-349,454
| -19% | -USD 12.4 M | 0.01% | 850 |
|
|
2019
Q2 | USD 72.7 M | Comprar |
1,850,796
+643,494
| +53% | +USD 25.5 M | 0.02% | 678 |
|
|
2019
Q1 | USD 48.9 M | Vender |
1,207,302
-280,691
| -19% | -USD 10.5 M | 0.01% | 847 |
|
|
2018
Q4 | USD 48.2 M | Comprar |
1,487,993
+390,902
| +36% | +USD 15.8 M | 0.01% | 835 |
|
|
2018
Q3 | USD 56.4 M | Vender |
1,097,091
-147,819
| -12% | -USD 7.4 M | 0.01% | 887 |
|
|
2018
Q2 | USD 62.7 M | Vender |
1,244,910
-166,877
| -12% | -USD 8.46 M | 0.02% | 793 |
|
|
2018
Q1 | USD 72.1 M | Comprar |
1,411,787
+185,003
| +15% | +USD 9.9 M | 0.02% | 734 |
|
|
2017
Q4 | USD 64.5 M | Comprar |
1,226,784
+304,238
| +33% | +USD 15.1 M | 0.02% | 776 |
|
|
2017
Q3 | USD 45.1 M | Comprar |
922,546
+220,713
| +31% | +USD 10.5 M | 0.01% | 962 |
|
|
2017
Q2 | USD 33.9 M | Vender |
701,833
-9,266
| -1% | -USD 427 k | 0.01% | 1138 |
|
|
2017
Q1 | USD 30 M | Vender |
711,099
-5,940
| -0.8% | -USD 246 k | 0.01% | 1241 |
|
|
2016
Q4 | USD 30.3 M | Comprar |
717,039
+43,143
| +6% | +USD 1.76 M | 0.01% | 1195 |
|
|
2016
Q3 | USD 29.5 M | Vender |
673,896
-24,541
| -4% | -USD 1.1 M | 0.01% | 1171 |
|
|
2016
Q2 | USD 30.4 M | Comprar |
698,437
+436
| +0.1% | +USD 18.8 k | 0.01% | 1109 |
|
|
2016
Q1 | USD 30.8 M | Comprar |
698,001
+12,663
| +2% | +USD 536 k | 0.01% | 1034 |
|
|
2015
Q4 | USD 28.7 M | Comprar |
685,338
+116,653
| +21% | +USD 4.91 M | 0.01% | 1148 |
|
|
2015
Q3 | USD 22.2 M | Comprar |
568,685
+64,095
| +13% | +USD 2.61 M | 0.01% | 1295 |
|
|
2015
Q2 | USD 21 M | Comprar |
504,590
+93,440
| +23% | +USD 3.99 M | 0.01% | 1456 |
|
|
2015
Q1 | USD 17 M | Comprar |
411,150
+76,064
| +23% | +USD 2.94 M | 0.01% | 1587 |
|
|
2014
Q4 | USD 12.4 M | Comprar |
335,086
+141,947
| +73% | +USD 5.12 M | ﹤0.01% | 1866 |
|
|
2014
Q3 | USD 6.7 M | Comprar |
193,139
+57,032
| +42% | +USD 1.97 M | ﹤0.01% | 2380 |
|
|
2014
Q2 | USD 4.56 M | Comprar |
136,107
+75,101
| +123% | +USD 2.5 M | ﹤0.01% | 2748 |
|
|
2014
Q1 | USD 2.13 M | Vender |
61,006
-10,455
| -15% | -USD 366 k | ﹤0.01% | 3363 |
|
|
2013
Q4 | USD 2.54 M | Vender |
71,461
-5,161
| -7% | -USD 173 k | ﹤0.01% | 3199 |
|
|
2013
Q3 | USD 2.48 M | Vender |
76,622
-45,994
| -38% | -USD 1.5 M | ﹤0.01% | 3052 |
|
|
2013
Q2 | USD 4.32 M | Comprar |
+122,616
| Nuevas | +USD 4.26 M | ﹤0.01% | 2468 |
|
Otros fondos que tienen FMS en su cartera
Posición de Morgan Stanley en FMS: resumen de T2 2026
Morgan Stanley aumentó su participación en Fresenius Medical Care (FMS) en 75% durante T2 2026, al comprar aproximadamente USD 41.8 M y elevar la posición a 4,347,748 acciones con un valor de USD 98.3 M. La posición representa 0.01% de la cartera y ocupa el puesto #1579.
Morgan Stanley reportó por primera vez una posición en FMS en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 235 fondos que sigue Wall St. Rank mantienen una posición en FMS.
- Al cierre de T2 2026, Morgan Stanley tenía 4,347,748 acciones de Fresenius Medical Care con un valor de USD 98.3 M.
- Morgan Stanley compró 1,862,938 acciones de Fresenius Medical Care en T2 2026, por un monto estimado de USD 41.8 M.
- Fresenius Medical Care representó 0.01% de la cartera de Morgan Stanley en T2 2026 y fue su posición número 1579.
- Morgan Stanley reportó por primera vez una posición en Fresenius Medical Care en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 235 fondos que sigue Wall St. Rank tenían Fresenius Medical Care en cartera.
Según el Informe 13F de Morgan Stanley correspondiente a T2 2026, presentado el 13 ago 2026.